SCHEMBL21718315

SCHEMBL21718315

c1ccc(-c2ccc(-c3c4ccccc4cc4c3c3cccc5c6c(-c7ccc(-c8ccccc8)cc7)c7ccccc7cc6n4c35)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 2/20 0.38
ESR1 P03372 5/20 0.38
ESR2 Q92731 5/20 0.38
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP2D6 P10635 1/20 0.37
HSD17B1 P14061 1/20 0.37
CYP2B6 P20813 1/20 0.37
HSD17B2 P37059 1/20 0.37
ALOX5 P09917 2/20 0.36
HTR6 P50406 2/20 0.36
HPGD P15428 3/20 0.35
KDM4E B2RXH2 3/20 0.35
LMNA P02545 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
NQO2 P16083 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21718304 1.00 GPR84 (0.38) GPR84ESR1ESR2CYP1A2CYP3A4
SCHEMBL19563754 0.97 ALOX5 (0.38) GPR84ESR1ESR2CYP1A2CYP3A4
SCHEMBL21718118 0.94 CYP1A2 (0.37) GPR84ESR1ESR2CYP1A2CYP3A4
SCHEMBL21718052 0.92 HTR6 (0.35) GPR84ESR1ESR2CYP1A2CYP3A4
SCHEMBL21718319 0.92 HTR6 (0.38) GPR84ESR1ESR2CYP1A2CYP3A4
SCHEMBL22679439 0.91 ALOX5 (0.38) GPR84ESR1ESR2CYP1A2CYP3A4
SCHEMBL21718297 0.90 ESR1 (0.40) GPR84ESR1ESR2CYP1A2CYP3A4
SCHEMBL21718303 0.88 GPR84 (0.40) GPR84CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL21710716 0.87 HSD17B1 (0.33) GPR84ESR1ESR2CYP1A2CYP3A4
SCHEMBL21710717 0.87 HTR6 (0.35) GPR84CYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE LEF1, L1CAM, ESR2 GPR84 4370/4885ESR1 7/4885ESR2 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.